These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7652491)

  • 1. Current status of tumour markers.
    Schwartz MK
    Scand J Clin Lab Invest Suppl; 1995; 221():5-14. PubMed ID: 7652491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international proficiency study with the tumor marker CA 125.
    Zwirner M; Bieglmayer CH; Klapdor R; Kreienberg R; Lüthgens M
    Int J Biol Markers; 1990; 5(2):55-60. PubMed ID: 2283477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYFRA 21-1--clinical applications and analytical requirements.
    Ebert W; Bodenmüller H; Hölzel W
    Scand J Clin Lab Invest Suppl; 1995; 221():72-80. PubMed ID: 7544488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour markers: current status and future applications.
    Aziz K
    Scand J Clin Lab Invest Suppl; 1995; 221():153-5. PubMed ID: 7652488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical requirements and standardization of CA 15-3.
    van Dalen A
    Scand J Clin Lab Invest Suppl; 1995; 221():102-4. PubMed ID: 7652484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized training and proficiency testing. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Vooijs GP; Davey DD; Somrak TM; Goodell RM; Grohs DH; Knesel EA; Mango LJ; Mui KK; Nielsen ML; Wilbur DC
    Acta Cytol; 1998; 42(1):141-7. PubMed ID: 9479333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.
    Sturgeon CM; Hoffman BR; Chan DW; Ch'ng SL; Hammond E; Hayes DF; Liotta LA; Petricoin EF; Schmitt M; Semmes OJ; Söletormos G; van der Merwe E; Diamandis EP;
    Clin Chem; 2008 Aug; 54(8):e1-e10. PubMed ID: 18606634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour marker evaluation in patients with lung cancer.
    Seregni E; Botti C; Bogni A; Bombardieri E
    Scand J Clin Lab Invest Suppl; 1995; 221():67-71. PubMed ID: 7652492
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular marker test standardization.
    Koepke JA
    Cancer; 1992 Mar; 69(6 Suppl):1578-81. PubMed ID: 1540898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized screening devices and performance assessment: development of a policy towards automation. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Bartels PH; Bibbo M; Hutchinson ML; Gahm T; Grohs HK; Gwi-Mak E; Kaufman EA; Kaufman RH; Knight BK; Koss LG; Magruder LE; Mango LJ; McCallum SM; Melamed MR; Peebles A; Richart RM; Robinowitz M; Rosenthal DL; Sauer T; Schenck U; Tanaka N; Topalidis T; Verhest AP; Wertlake PT; Wilbur DC
    Acta Cytol; 1998; 42(1):59-68. PubMed ID: 9479324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.
    Kozinski M; Krintus M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2017 May; 54(3):143-172. PubMed ID: 28457177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST).
    Barker PE
    Ann N Y Acad Sci; 2003 Mar; 983():142-50. PubMed ID: 12724219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assurance in military medical research and medical radiation accident management.
    Hotz ME; Meineke V
    Health Phys; 2012 Aug; 103(2):221-5. PubMed ID: 22951484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of tumour markers: a review.
    Amayo AA; Kuria JG
    East Afr Med J; 2009 Dec; 86(12 Suppl):S76-83. PubMed ID: 21591514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the role of established tumour markers.
    Beastall GH; Cook B; Rustin GJ; Jennings J
    Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():5-18. PubMed ID: 2024935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Overview of Proficiency Testing and External Quality Assessment Programs of Laboratory Tests from the Standpoint of International Standardization].
    Miyachi H
    Rinsho Byori; 2015 Aug; 63(8):919-24. PubMed ID: 26638428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers.
    Wang HY; Hsieh CH; Wen CN; Wen YH; Chen CH; Lu JJ
    PLoS One; 2016; 11(6):e0158285. PubMed ID: 27355357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control and standardization of tumour marker tests.
    van Dalen A
    Tumour Biol; 1993; 14(2):131-5. PubMed ID: 8327837
    [No Abstract]   [Full Text] [Related]  

  • 19. Reference system for cholesterol measurements.
    Cooper GR; Myers GL
    Scand J Clin Lab Invest Suppl; 1990; 198():27-31. PubMed ID: 2189207
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.